Muller R - Search Results

1

JAK inhibitors in 2019, synthetic review in 10 points.

Muller R. Muller R. Eur J Intern Med. 2019 Aug;66:9-17. doi: 10.1016/j.ejim.2019.05.022. Epub 2019 Jun 6. Eur J Intern Med. 2019. PMID: 31178258 Review.

2

Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.

Muller R. Muller R. Rheumatol Int. 2021 Jul;41(7):1189-1202. doi: 10.1007/s00296-021-04868-6. Epub 2021 Apr 24. Rheumatol Int. 2021. PMID: 33893862 Free PMC article. Review.

3

Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?

Cauchois R, Muller R, Lagarde M, Dignat-George F, Tellier E, Kaplanski G. Cauchois R, et al. Among authors: muller r. J Clin Med. 2023 Jan 18;12(3):758. doi: 10.3390/jcm12030758. J Clin Med. 2023. PMID: 36769407 Free PMC article. Review.

4

Characteristics of Systemic Sclerosis patients with positive anti-Th/To antibodies: About 6 patients and literature review.

Muller R, Benyamine A, Bertin D, Harlé JR, Kaplanski G, Mazodier K, Reynaud-Gaubert M, Granel B, Bardin N. Muller R, et al. Rev Med Interne. 2020 Jul;41(7):440-445. doi: 10.1016/j.revmed.2019.12.020. Epub 2020 Feb 13. Rev Med Interne. 2020. PMID: 32063422 Review.

5

Ocular Inflammation Induced by Immune Checkpoint Inhibitors.

Chaudot F, Sève P, Rousseau A, Maria ATJ, Fournie P, Lozach P, Keraen J, Servant M, Muller R, Gramont B, Touhami S, Mahmoud H, Quintart PA, Dalle S, Lambotte O, Kodjikian L, Jamilloux Y. Chaudot F, et al. Among authors: muller r. J Clin Med. 2022 Aug 25;11(17):4993. doi: 10.3390/jcm11174993. J Clin Med. 2022. PMID: 36078923 Free PMC article.

6

The authors reply.

Muller R, Lebrun G. Muller R, et al. Kidney Int. 2021 Sep;100(3):710-711. doi: 10.1016/j.kint.2021.05.025. Kidney Int. 2021. PMID: 34420666 No abstract available.

7

Strawberry gingivitis.

Muller R, Lebrun G. Muller R, et al. Kidney Int. 2021 Dec;100(6):1353. doi: 10.1016/j.kint.2021.04.013. Kidney Int. 2021. PMID: 34802567 No abstract available.

8

"True" Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies.

Arcani R, Cauchois R, Suchon P, Weber S, Jean R, Jarrot PA, Rey L, Venton G, Koubi M, Muller R, Bertin D, Mège JL, Kaplanski G, Bardin N. Arcani R, et al. Among authors: muller r. Semin Thromb Hemost. 2023 Feb;49(1):97-102. doi: 10.1055/s-0042-1758118. Epub 2022 Nov 6. Semin Thromb Hemost. 2023. PMID: 36335917 Free article. No abstract available.

9

Correspondence on: 'Dupilumab as a novel steroid-sparing treatment for IgG₄-related disease' by Simpson et al.

Ebbo M, De Sainte-Marie B, Muller R, Piperoglou C, Grados A, Vély F, Schleinitz N. Ebbo M, et al. Among authors: muller r. Ann Rheum Dis. 2022 Feb;81(2):e26. doi: 10.1136/annrheumdis-2020-217010. Epub 2020 Jan 29. Ann Rheum Dis. 2022. PMID: 31996366 No abstract available.

10

Actualités dans le lupus et le syndrome des anticorps antiphospholipides: Systemic lupus and antiphospholipid syndrome: highlights.

Muller R, Crickx E. Muller R, et al. Rev Med Interne. 2021 Sep;42(10S):10S14-10S16. doi: 10.1016/S0248-8663(21)00659-7. Rev Med Interne. 2021. PMID: 34598744 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,471 results

Search Page

Filters